Recent Developments in the Treatment of Clear Cell, Renal Cell Carcinoma: Essential Insights and Updates for the Healthcare Team

Access Activity

Overview / Abstract:

Target Audience
Oncology, Managed care and Specialty Pharmacists and Oncology Nurses/Nurse Practitioners

Program Overview
The goal of this educational initiative is to equip oncology nurse practitioners and nurses, as well as oncology, managed care, and specialty care pharmacists with the knowledge to apply findings from risk scoring systems used to stratify cases of clear cell renal cell carcinoma for treatment selection, differentiate among an expanding array of combination regimens containing immune checkpoint inhibitors and targeted therapies, and elevate the standard of care for patients by mitigating the incidence and severity of immune-related adverse events tied to the use of medications gaining widespread adoption in routine clinical practice.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Discuss factors used to stratify patients diagnosed with clear cell renal cell carcinoma to determine treatment
Describe the efficacy and tolerability profiles of current and emerging combination regimens for clear cell renal cell carcinoma consisting of targeted therapies and immune checkpoint inhibitors
Formulate individualized care strategies that minimize the severity and frequency of adverse events associated with combination strategies for clear cell renal cell carcinoma

Expiration

Jun 18, 2025

Discipline(s)

Nursing CNE, Pharmacy CPE

Format

Online

Credits / Hours

1.25 Nursing Contact Hours (0.5 contact hours of pharmacotherapy credit)

Accreditation

ANCC, AANP

Presenters / Authors / Faculty

Faculty
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC
Director of Pharmacy | Minnesota Oncology
St. Paul, MN
Assistant Professor of Pharmacy | Mayo Clinic College of Medicine
Rochester, MN

Lisa M. Holle, PharmD, BDOP, FHOPA, FISOPP
Lisa M. Holle, PharmD, BDOP, FHOPA, FISOPP
Clinical Oncology Pharmacist Faculty
Department of Pharmacy
UConn Health Carole & Ray Neag Comprehensive Cancer Center
Farmington, CT

Virginia J. Seery, MSN, RN, ANP-BC, AOCNP
Virginia J. Seery, MSN, RN, ANP-BC, AOCNP
Nurse Practitioner
Oncology"Immunotherapy, Melanoma, Renal Cell Cancer Specialty
Beth Israel Deaconess Medical Center
Boston, MA

Sponsors / Supporters / Grant Providers

Merck & Co., Inc.

Keywords / Search Terms

Relias LLC Relias LLC., FreeCME., Renal Cell Carcinoma, Clear Cell Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map